Physician profile
Patrick Daniel Huck
NPI 1821280223
$1,140.15
in general payments reported to CMS, 2019-2025
22 companies · $23.39 in 2025
The $23.39 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $116 · 2021: $186 · 2022: $415 · 2023: $141 · 2024: $16.53 · 2025: $23.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $254.76 | 2020-2023 | Prevena |
| Ethicon US, LLC | $204.71 | 2019-2021 | |
| Allergan, INC. | $164.52 | 2019-2022 | |
| Smith+Nephew, INC. | $81.41 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $70.10 | 2022 | |
| Intuitive Surgical, INC. | $53.57 | 2022 | |
| Abbott Laboratories | $36.13 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $33.40 | 2021 | |
| Polynovo North America LLC | $27.29 | 2023 | |
| Olympus America INC. | $24.94 | 2021 | |
| Merz Pharmaceuticals, LLC | $23.39 | 2025 | Xeomin |
| Mentor Worldwide LLC | $20.95 | 2019 | |
| Genentech USA, INC. | $19.98 | 2019 | |
| Integra Lifesciences Corporation | $16.53 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $15.63 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $15.10 | 2019 | |
| Boston Scientific Corporation | $14.67 | 2023 | Superion Indirect Decompression System |
| Bioventus LLC | $13.51 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $13.10 | 2019 | |
| Polarityte, INC. | $12.56 | 2020 | |
| Tela Bio, INC. | $12.45 | 2022 | |
| Coopersurgical, INC. | $11.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Huck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.